Cargando…

Iron Supplementation and the Risk of Bronchopulmonary Dysplasia in Extremely Low Gestational Age Newborns

BACKGROUND: To determine the relationship between iron exposure and the development of bronchopulmonary dysplasia (BPD). METHODS: A secondary analysis of the PENUT Trial dataset. The primary outcome was BPD at 36 weeks gestational age and primary exposures of interest were cumulative iron exposures...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia, Melissa R, Comstock, Bryan A, Patel, Ravi M, Tolia, Veeral N, Josephson, Cassandra D, Georgieff, Michael K, Rao, Raghavendra, Monsell, Sarah E, Juul, Sandra E, Ahmad, Kaashif A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763546/ https://www.ncbi.nlm.nih.gov/pubmed/35725917 http://dx.doi.org/10.1038/s41390-022-02160-2

Ejemplares similares

Early Blood Gas Predictors of Bronchopulmonary Dysplasia in Extremely Low Gestational Age Newborns
por: Sriram, Sudhir, et al.
Publicado: (2014)

Bronchopulmonary Dysplasia: Ongoing Challenges from Definitions to Clinical Care
por: Nuthakki, Sushma, et al.
Publicado: (2023)

In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017)

Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
por: McEvoy, Cindy T., et al.
Publicado: (2020)

Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia
por: Madden, J, et al.
Publicado: (2010)

Prediction Model for Bronchopulmonary Dysplasia in Preterm Newborns
por: Jassem-Bobowicz, Joanna Maria, et al.
Publicado: (2021)

Association between colonization of the respiratory tract with Ureaplasma species and bronchopulmonary dysplasia in newborns with extremely low gestational age: a retrospective study
por: Gobec, Katja, et al.
Publicado: (2023)

Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23–26 Weeks Gestation
por: Kim, Jin Kyu, et al.
Publicado: (2016)

Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022)

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
por: Trittmann, J. K., et al.
Publicado: (2013)

Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
por: Mowitz, Meredith E., et al.
Publicado: (2019)

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks
por: Geetha, Odattil, et al.
Publicado: (2021)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Ventilator flow data predict bronchopulmonary dysplasia in extremely premature neonates
por: Bentsen, Mariann H., et al.
Publicado: (2018)

BMP7 regulates lung fibroblast proliferation in newborn rats with bronchopulmonary dysplasia
por: Sun, Yanli, et al.
Publicado: (2018)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia in Preterm Infants Born at Less Than 32 Weeks Gestation
por: Xu, Yan-Ping
Publicado: (2016)

Bronchopulmonary dysplasia in neonates born to mothers with preeclampsia: Impact of small for gestational age
por: Dravet-Gounot, Pauline, et al.
Publicado: (2018)

Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia
por: Cohen, Jennifer, et al.
Publicado: (2007)

Time to Regain Birthweight and Association with Neurodevelopmental Outcomes among Extremely Preterm Newborns
por: Valentine, Gregory, et al.
Publicado: (2023)

State of the Art Review: Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants
por: Foglia, Elizabeth E., et al.
Publicado: (2017)

Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
por: Vu, Phuong T., et al.
Publicado: (2021)

Risk factors that affect the degree of bronchopulmonary dysplasia: Comparison by severity in the same gestational age
por: Kim, Sung-Ha, et al.
Publicado: (2020)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Whole genome methylation and transcriptome analyses to identify risk for cerebral palsy (CP) in extremely low gestational age neonates (ELGAN)
por: Massaro, An N., et al.
Publicado: (2021)

Cord Blood Levels of IL-6, IL-8 and IL-10 May Be Early Predictors of Bronchopulmonary Dysplasia in Preterm Newborns Small for Gestational Age
por: Rocha, Gustavo, et al.
Publicado: (2012)

Biomarker Potential of the Soluble Receptor for Advanced Glycation End Products to Predict Bronchopulmonary Dysplasia in Premature Newborns
por: Go, Hayato, et al.
Publicado: (2021)

Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia
por: Zhu, Yuting, et al.
Publicado: (2015)

Serum Eotaxin-1 is Increased in Extremely Low Birth Infants with Bronchopulmonary Dysplasia or Death
por: Kandasamy, Jegen, et al.
Publicado: (2015)

Where Are We Now with the Role of Steroids in the Management of Bronchopulmonary Dysplasia in Extremely Premature Babies?
por: Hurley, Matthew, et al.
Publicado: (2016)

Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Bronchopulmonary dysplasia is associated with reduced oral nitrate reductase activity in extremely preterm infants
por: Gentle, Samuel J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0g7nonvhel5qnp7feoues0qg5m